-
Eur Radiol: How much do you know about MRI diagnosis of ovarian tumors?
Time of Update: 2021-03-20
diagnosis Recently, a study published in the journal European Radiology has developed a deep learning algorithm that uses convolutional neural networks on conventional MR imaging to identify benign and malignant ovarian lesions, and establishes a preoperative evaluation of non-invasive ovarian lesions.
-
Lancet oncol: Phase 3 | Pembrolizumab as a second and third-line therapy for metastatic triple-negative breast cancer
Time of Update: 2021-03-20
In summary, the use of pembrolizumab in previously treated metastatic triple-negative breast cancer failed to significantly prolong the overall survival of patients compared with chemotherapy .
1016/S1470-2045(20)30754-3" target="_blank" rel="noopener">Pembrolizumab versus investigator-choice chemotherapy for metastatic triple-negative breast cancer (KEYNOTE-119): a randomised, open-label, phase 3 trial .
-
J Hematol Oncol: KMT2 family gene mutations can predict cancer patients' response to immune checkpoint therapy
Time of Update: 2021-03-20
67 e -04) eIn conclusion, the results of this study indicate that KMT2 family gene mutations can be used as potential predictors of response to ICT treatment in a variety of cancer patients, emphasizing the importance of genome maps in immunotherapy .
-
PRS: Improve the quality of life of breast cancer patients!
Time of Update: 2021-03-20
Breast cancerThe purpose of this study was to evaluate immediate reconstruction lymphatic or lymphatic microsurgery prevention of healing methods postoperative incidence of lymphedema.
-
Nat Commun: Deep learning helps histopathological identification
Time of Update: 2021-03-20
Recently, researchers have proposed a method that uses human interpretable image features (HIFs) to predict clinically relevant molecular phenotypes from entire histopathological images.
Nature Communications (2 Human-interpretable image features derived from densely mapped cancer pathology slides predict diverse molecular phenotypes 021) Leave a message here
-
The Ombudsman of Hong Kong’s Counterfeit Cervical Cancer Vaccine Made Four Suggestions After Investigation
Time of Update: 2021-03-20
In mid-2019, a private medical institution in Hong Kong was revealed to be suspected of providing counterfeit HPV vaccines.
The Department of Health and Customs took swift action after the incident was revealed and stepped up investigations of private medical institutions.
-
Lancet Oncology: Is the current standard radiotherapy regimen reasonable for limited-stage small cell lung cancer?
Time of Update: 2021-03-20
references:High-dose versus standard-dose twice-daily thoracic radiotherapy for patients with limited stage small-cell lung cancer: an open-label, randomised, phase 2 trial.
1016/S1470-2045(20) 30742-7High-dose versus standard-dose twice-daily thoracic radiotherapy for patients with limited stage small-cell lung cancer: an open-label, randomised, phase 2 trial.
-
JCO: Entratinib is safe and effective in the treatment of locally advanced or metastatic ROS1 fusion-positive NSCLC, and the intracranial ORR can reach 79.2%
Time of Update: 2021-03-20
Therefore, researchers have a new idea to extend the follow-up time and confirm in a larger population that Entratinib can be used in patients with locally advanced or metastatic ROS proto-oncogene 1 (ROS1) fusion-positive non-small cell lung cancer (including baseline The effectiveness and safety of patients with central transfer?This study included adult patients with locally advanced or metastatic ROS1 fusion-positive NSCLC, with or without CNS metastasis.
-
CHMP recommends approval of Sarclisa (isatuximab) in combination with carfilzomib and dexamethasone for the treatment of recurrent multiple myeloma
Time of Update: 2021-03-20
Recently, the European Medicines Management Agency (EMA) Committee for Medicinal suggested use (CHMP) approved Sarclisa (isatuximab) and carfilzomib and dexamethasone (Kd) used in combination relapsed multiple myeloma (MM), these patients previously Have received at least one therapy.
-
Cell Death Differ: USP39 and TRIM26 affect the occurrence and development of hepatocellular carcinoma by antagonizing the ubiquitination of ZEB1
Time of Update: 2021-03-20
The results of this study revealed a new mechanism by which USP39 and TRIM26 regulate the level of ZEB1 ubiquitination and affect the proliferation and migration of HCC cells.
-
Chongqing Cancer Hospital creates exclusive radiotherapy area "H28 Healing Planet" for children
Time of Update: 2021-03-20
It is reported that the name "H28 Healing Planet" comes from the 28-day cycle of children's radiotherapy.
" Wang Ying said, children who used to be hospitalized in radiotherapy centers can only be mixed with adult patients, and adult patients are passed on due to pain, vomiting, etc.
-
Academician Ding Jian appointed as Dean of Zhejiang University Cancer Institute
Time of Update: 2021-03-20
Molecular targeted immunityIn January 2020, focusing on the urgent needs of national strategy, the frontiers of international academics, and the major issues facing human diseases and health, Zhejiang University coordinated the development of disciplines and established the Zhejiang University Cancer Institute, which will screen , diagnose and treat major malignant tumors early.
-
Breast: Olanzapine can effectively prevent nausea and vomiting caused by chemotherapy in Chinese breast cancer patients
Time of Update: 2021-03-20
gov/31978815/" target="_blank" rel="noopener">A randomized study of olanzapine-containing versus standard antiemetic regimens for the prevention of chemotherapy-induced nausea and vomiting in Chinese breast cancer patients .
gov/31978815/" target="_blank" rel="noopener">A randomized Study of the olanzapine-containing versus at The Standard antiemetic regimens for Prevention of Chemotherapy-induced Nausea and vomiting in Chinese Breast Cancer patients in this message
-
Cancer Discovery: Zou Weiping's team reveals the mechanism by which the loss of optic neuroprotein mediates immune escape in colorectal cancer
Time of Update: 2021-03-20
Du Wan and Professor Hua Fang are co-first authors) published a titled Loss of optineurin drives cancer immune evasion via palmitoylation-dependent IFNGR1 lysosomal sorting and on Cancer Discovery.
-
JAMA Netw Open: Carrying status of carcinogenic variants in breast and ovarian cancer patients
Time of Update: 2021-03-20
This study used data from germline genetic testing in the Bahamas, Cayman Islands, Barbados, Dominica, Jamaica, Haiti and Trinidad and Tobago from June 2010 to June 2018.
com/journals/jamanetworkopen/fullarticle/2776805" target="_blank" rel="noopener">Among Variants Sequencing for Pathogenic Gene Adults With Breast and Ovarian Cancer in The Caribbean JAMA in this message
-
Eur Radiol: What is the impact of low-grade glioma DNA copy number subtypes on the prognosis?
Time of Update: 2021-03-20
This preliminary radiogenomic analysis shows that MR-based preoperative nomograms can provide personalized predictions of DNA copy number subtypes for LGG patients.
This preliminary radiogenomic analysis shows that MR-based preoperative nomograms can provide personalized predictions of DNA copy number subtypes for LGG patients.
-
Concerned about "her health", members of the National Committee of the Chinese People's Political Consultative Conference called on cervical cancer prevention and control to gradually move forward
Time of Update: 2021-03-20
Many members of the National Committee of the Chinese People's Political Consultative Conference called for the prevention and control of cervical cancer to be gradually moved forward to increase the HPV vaccination rate.
-
Nat Commun: Polygenic Risk Score (PHS) to assess the risk of prostate cancer
Time of Update: 2021-03-20
The study used polygenic risk scores to classify the risk of male prostate cancer patients in a multi-ethnic data set to assess whether they have any aggressive and fatal prostate cancer.
-
Liver Int: Pathological predictors of late recurrence of hepatocellular carcinoma in chronic liver disease
Time of Update: 2021-03-20
In summary, the combination of pSTAT3, pERK1/2 and SYK immune expression with high lobular inflammatory activity and liver cirrhosis (fibrosis) can predict the recurrence of advanced HCC .
-
NCC: To do this, nearly half of all cancer deaths in our country can be prevented!
Time of Update: 2021-03-20
cn/ipsen/sporty/show-details/3074/2">Digestive breast cancerRecently, experts from the Chinese Academy of Medical Sciences and Peking Union Medical College National Cancer Center reviewed the trend of cancer burden in China, cancer-related risk factors and prevention strategies.
